The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...

(MENAFN- GlobeNewsWire - Nasdaq) Nanoparticle technology offers significant opportunities in pharma and biomedicine, particularly in drug delivery, diagnostics, and therapeutic innovations. With ...

After walking away from cell therapy and narrowing its focus to just three modalities, Takeda is doubling down on its remaining strategic commitment by reupping a pact with AI drug designer Nabla Bio.

Shares of Spruce Biosciences, Inc. (NASDAQ:SPRB) are surging Monday after the biotech company shared an important regulatory update about one of its therapy treatments. What To Know: Spruce ...

Still, the recently released 2025-30 Arizona Bioscience Roadmap, as well as several academic, community and local government ...

Shares of the microcap biotech Spruce Biosciences just had their best day on record after it said the Food and Drug Administration had granted it a special designation that would allow its ...

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

This story was originally published by CalMatters. Sign up for their newsletters. At CART High near Fresno, there is no gum stuck to the floor. The saffron-yellow walls are unmarred by graffiti.

MGM on Tuesday unexpectedly withdrew its casino license application for Empire City in Yonkers. “Today, MGM Resorts made the difficult decision to withdraw its application for a commercial casino ...

Biotech at Hub101! October 27, 2025 Hub101 presented a panel of speakers to discuss the growing biotech industry in the region. The SOM held three Masterclasses during Homecoming for CLU alumni ...